Advertisement
Advertisement

GLYC

GLYC logo

GlycoMimetics Inc

0.2239
USD
-0.0092
-3.95%
Dec 18, 15:59 UTC -5
Closed
...

GlycoMimetics Inc Profile

About

GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.

Info & Links

CEO

Harout Semerjian

Headquarters

9708 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.glycomimetics.com

Auditor

Ernst & Young LLP

Share holders

21

Employees

35

GlycoMimetics Inc Statistics

Valuation Measures

Market Capitalization2

14.44M

Enterprise Value

45.37K

Enterprise Value/EBITDA(ttm)

-0.00

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

1.35

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-160.93%

Return on Invested Capital(ttm)

-197.45%

Return on Assets(ttm)

-132.85%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-42.25M

Net Income Available to Common(ttm)

-39.73M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.77

52-Week Change

-86.09%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

64.48M

Dividend Yield

0.00%

Float4

58.87M

% Held by Insiders

8.70%

% Held by Institutions

75.19%

Balance Sheet

Total Cash(mrq)

14.39M

Total Cash Per Share(mrq)

0.22

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.62%

Quick Ratio(mrq)

3.62%

Book Value Per Share(mrq)

0.18

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.42

Free Cash Flow(ytd)

-27.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement